CHGCY Stock: Chugai Pharmaceutical Co., Ltd. Stock Price, Analysis & Insights
Get live CHGCY stock price $23.32, comprehensive Chugai Pharmaceutical Co., Ltd. stock analysis, charts, news, and expert forecast. Real-time CHGCY stock data and investment insights.
Loading chart data...
Chugai Pharmaceutical Co., Ltd. (CHGCY) Overview
Chugai Pharmaceutical Co., Ltd. (CHGCY) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - General industry . As of the latest trading session, CHGCY trades at $23.32 with a market capitalization of 76.76B . Over the past 52 weeks, CHGCY has traded between $19.50 and $34.84 , with the current price positioned at approximately 25% of this range ....
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - General)
- Market cap: 76.76B
- Current price: $23.32
- 52-week range: $19.50 - $34.84
- P/E ratio: 28.44
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Chugai Pharmaceutical Co., Ltd., along with its affiliated entities, is a global pharmaceutical company deeply involved in the discovery, development, production, marketing, and distribution of medicines. Its diverse product portfolio addresses a ran...
Company Information
- CEO
- Osamu Okuda
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 5026
Contact Information
- Address
- Nihonbashi Mitsui Tower
- Country
- JP
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 28.4)
✓ Lower volatility stock (Beta: 0.55) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Chugai Pharmaceutical Co., Ltd. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Chugai Pharmaceutical Co., Ltd.
- ⚠Investors should consider how Chugai Pharmaceutical Co., Ltd. fits within their overall portfolio allocation
Market Cap
76.76B
P/E Ratio (TTM)
28.44
Beta
0.55
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare CHGCY with peer companies:
- Price
- $73.80
- Market cap
- 35.34B
- Price
- $15.00
- Market cap
- 27.29B
- Price
- $15.42
- Market cap
- 28.06B
- Price
- $25.12
- Market cap
- 100.73B
- Price
- $158.38
- Market cap
- 52.98B
- Price
- $46.75
- Market cap
- 61.82B
- Price
- $158.20
- Market cap
- 68.78B
- Price
- $31.35
- Market cap
- 68.15B
- Price
- $40.35
- Market cap
- 45.15B
- Price
- $54.23
- Market cap
- 79.24B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.